Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigenJC Aguilar, Gerardo Guillén, Yadira Lobaina et al.|Immunology and Cell Biology|2004Cited by 87
Immunological characterization of two hepatitis B core antigen variants and their immunoenhancing effect on co-delivered hepatitis B surface antigenYadira Lobaina, José Aguilar, Daniel Palenzuela et al.|Molecular Immunology|2004Cited by 46
Virus-Like Particles as vaccine antigens and adjuvants: application to chronic disease, cancer immunotherapy and infectious disease preventive strategiesGerardo Guillén, Luís Herrera, Julio Aguilar et al.|Procedia in Vaccinology|2010Cited by 21
Nasal route favors the induction of CD4 + T cell responses in the liver of HBV-carrier mice immunized with a recombinant hepatitis B surface- and core-based therapeutic vaccineMaryline Bourgine, Marie‐Louise Michel, Sandrine Crabé et al.|Antiviral Research|2018Cited by 13
Influence of Aluminum-Based Adjuvant on the Immune Response to Multiantigenic FormulationEnrique V. Iglesias, Julio Aguilar, Dioslaida Urquiza et al.|Viral Immunology|2006Cited by 12